京都大学 島津 裕 Sci Rep.2023 Mar 29;13(1):5159.

Efficacy of elotuzumab for multiple myeloma in reference to
lymphocyte counts and kappa/lambda ratio or B2 microglobulin

https://pubmed.ncbi.nlm.nih.gov/36991096/